Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SpringWorks Therapeutics, Inc. | Chief Financial Officer | Common Stock | 59.3K | $2.46M | $41.53 | Jan 8, 2024 | Direct |
SpringWorks Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 60K | Jan 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SWTX | SpringWorks Therapeutics, Inc. | Jan 4, 2024 | 4 | -$215K | 4 | Jan 8, 2024 | Chief Financial Officer |
SWTX | SpringWorks Therapeutics, Inc. | Jan 7, 2023 | 1 | -$28.8K | 4 | Jan 10, 2023 | Chief Financial Officer |
SWTX | SpringWorks Therapeutics, Inc. | Jan 5, 2023 | 4 | -$65.3K | 4 | Jan 9, 2023 | Chief Financial Officer |
SWTX | SpringWorks Therapeutics, Inc. | Jan 7, 2022 | 1 | -$73.3K | 4/A | Jan 14, 2022 | Chief Financial Officer |
SWTX | SpringWorks Therapeutics, Inc. | Jan 6, 2022 | 2 | $0 | 4 | Jan 10, 2022 | Chief Financial Officer |